🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT03424174
Active, not recruiting Not applicable

Clinical Outcome and Cytokine Expression After TKA

NCT03424174 · tracked via the Priya Life Science Germany tracker
Phase
Not applicable
Started
2017-01-04
Last updated
2024-08-07

Condition(s) studied

Osteoarthritis

Investigational drug(s) / intervention(s)

Coated Total Knee ArthroplastyStandard Total Knee Arthroplasty

Coated Total Knee Arthroplasty: Implantation coated Total Knee Arthroplasty

Standard Total Knee Arthroplasty: Implantation StandardTotal Knee Arthroplasty

Study summary

Comparison of coated and uncoated TKA with regard to cytokine expression and clinical results

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Primary and secondary osteoarthritis * understanding of german language Exclusion Criteria: * necessity of constrained TKA * existence of other joint implants

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University Center of Orthopaedics and Traumatology, University Medicine Carl Gustav Carus Dresden, TU Dresden Dresden Saxony

More Technische Universität Dresden trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03424174 on ClinicalTrials.gov ↗ ← All trials in Germany